Senseonics Holdings, Inc. (SENS)

NYSEAMERICAN: SENS · IEX Real-Time Price · USD
0.391
+0.006 (1.66%)
Jun 14, 2024, 4:00 PM EDT - Market closed
1.66%
Market Cap 207.79M
Revenue (ttm) 23.30M
Net Income (ttm) -80.59M
Shares Out 530.89M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,650,875
Open 0.389
Previous Close 0.385
Day's Range 0.383 - 0.396
52-Week Range 0.383 - 1.050
Beta 0.82
Analysts Buy
Price Target 1.25 (+219.37%)
Earnings Date Aug 8, 2024

About SENS

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare provider... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1996
Employees 132
Stock Exchange NYSEAMERICAN
Ticker Symbol SENS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for SENS stock is "Buy." The 12-month stock price forecast is $1.25, which is an increase of 219.37% from the latest price.

Price Target
$1.25
(219.37% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association's 84th Scientific Sessions

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

1 day ago - Business Wire

Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

16 days ago - Business Wire

Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

4 weeks ago - Business Wire

Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management

GERMANTOWN, Md. & CHESTERFIELD, Mo.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantab...

4 weeks ago - Business Wire

Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

5 weeks ago - Business Wire

Senseonics Holdings, Inc. to Participate in Upcoming Conferences

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

6 weeks ago - Business Wire

Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

6 weeks ago - Business Wire

Eversense® CGM System Receives iCGM Designation by the US FDA

GERMANTOWN, Md. & PARSIPPANY, N.J.--(BUSINESS WIRE)--Eversense® CGM System Receives iCGM Designation by the US FDA.

6 weeks ago - Business Wire

SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS

Eligible individuals in the U.S. will pay $99 out of pocket for each 6-month CGM system, offering each year of continuous glucose monitoring for just $200* PARSIPPANY, N.J. , March 12, 2024 /PRNewswir...

3 months ago - PRNewsWire

Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

3 months ago - Business Wire

Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

3 months ago - Business Wire

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

3 months ago - Business Wire

Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

4 months ago - Business Wire

Medicare Coverage Significantly Expanded for the Eversense E3 CGM System

PARSIPPANY, N.J.--(BUSINESS WIRE)--Ascensia Diabetes Care, a global diabetes care company, and Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development ...

4 months ago - Business Wire

MEDICARE COVERAGE SIGNIFICANTLY EXPANDED FOR THE EVERSENSE E3 CGM SYSTEM

The decision is further recognition of Eversense as an important option for people with diabetes PARSIPPANY, N.J. , Feb. 12, 2024 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company...

4 months ago - PRNewsWire

PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care

TOKYO--(BUSINESS WIRE)--PHC Holdings Corporation (TSE: 6523) (hereafter PHCHD), the parent company of Ascensia Diabetes Care, a global diabetes care company, along with Senseonics Holdings, Inc. (NYSE...

4 months ago - Business Wire

Senseonics Holdings, Inc. Announces Business Updates

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

5 months ago - Business Wire

Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

7 months ago - Business Wire

Senseonics Holdings, Inc. to Participate in the Stifel 2023 Healthcare Conference

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

7 months ago - Business Wire

Senseonics Holdings, Inc Schedules Third Quarter 2023 Earnings Release and Conference Call for November 9, 2023 at 4:30 p.m. Eastern Time

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

8 months ago - Business Wire

Ascensia Diabetes Care and Senseonics Announce ‘The CGM for Real Life' Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes

PARSIPPANY, N.J. & GERMANTOWN, Md.--(BUSINESS WIRE)--Ascensia Diabetes Care, a global diabetes care company, and Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused o...

8 months ago - Business Wire

Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

9 months ago - Business Wire

Senseonics Holdings, Inc. to Participate in the Gilmartin Group Emerging Growth Company Showcase

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

9 months ago - Business Wire

Senseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules Capital

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

Other symbols: HTGC
9 months ago - Business Wire

Senseonics Holdings, Inc. Reports Second Quarter 2023 Financial Results

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

11 months ago - Business Wire